Russia stocks lower at close of trade; MOEX Russia Index unchanged

Alexander & Baldwin (NYSE:ALEX – Get Free Report) released its quarterly earnings data on Friday. The financial services provider reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.21). The firm had revenue of $50.99 million during the quarter, compared to analyst estimates of $49.99 million. Alexander & Baldwin…

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Aptos”,sans-serif; mso-ascii-font-family:Aptos; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Aptos; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual;} March S&P E-mini futures: The ES is headed much higher over the coming months. Support is 6500….

Normal 0 false false false EN-US X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:”Table Normal”; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:””; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:8.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:12.0pt; font-family:”Aptos”,sans-serif; mso-ascii-font-family:Aptos; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Aptos; mso-hansi-theme-font:minor-latin; mso-font-kerning:1.0pt; mso-ligatures:standardcontextual;} September S&P E-mini futures:  Inflation is coming down and the Fed is unlikely to tighten any more….

The TheraPharm technology has potentially broad application in the diagnosis and treatment of haematologic diseases such as blood cancers, infection management and a variety of immunodeficiency diseases. TheraPharm already has a diagnostic imaging product approved in Europe and marketed as Scintimun targeting white blood cells, for the purpose of locating areas of infection in patients…